SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Valeant Squirms as Endo International Makes Competing Offer for Salix
March 11, 2015
 · 
4 min read
Biowarfare Company Emergent's Cancer Spinoff Aptevo Therapeutics to Employ 70 - 90 in Seattle
Deals
Ackman Gobbles Up Almost Five Percent Stake in Valeant
March 10, 2015
 · 
5 min read
Job Trends
Valeant Starts Chopping Dendreon Employees
March 3, 2015
 · 
2 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Bay
EXCLUSIVE: Evercore ISI Breaks Down Valeant / Salix Deal By the Numbers
February 23, 2015
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Spending Spree Continues as Valeant Officially Snags Salix for $14.5 Billion
February 22, 2015
 · 
4 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Endo Pharmaceuticals Rumored to be Battling Shire, Valeant for Salix’s Affections
February 18, 2015
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Look Out Valeant, Shire Wants to Continue Spending Spree With Salix Bid
February 13, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Valeant Secures Financing to Make Rumored $9.6 Billion Bid for Salix
February 12, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
It’s Official: Valeant to Buy Bankrupt Vaccine Maker for $400 Million Cash
February 11, 2015
 · 
2 min read
Load More
IN THE PRESS
Valeant Provides Financial Guidance Update
December 16, 2015
 · 
4 min read
Policy
QLT Inc. Commences Breach Of Contract Action Against Valeant
December 16, 2015
 · 
3 min read
BioMidwest
Embattled Valeant Cuts Prices in Walgreens Distribution Pact
December 15, 2015
 · 
9 min read
Business
Under Mounting Scrutiny, Valeant Hires a DC Attorney and Crisis PR Experts with Political Connections
December 14, 2015
 · 
1 min read
Deals
Struggling Valeant Considers Unloading Contact Lens Maker
December 9, 2015
 · 
1 min read
Could Valeant Be Making a Comeback?
December 2, 2015
 · 
1 min read
Ackman Tries to Stop the Bleeding By Increasing Valeant Stake to 9.9%
November 24, 2015
 · 
1 min read
Business
Valeant’s Future Examined and How Ackman Seems to Be in Control Rather than CEO Pearson
November 23, 2015
 · 
1 min read
Valeant To Hold Investor Day On December 16
November 20, 2015
 · 
3 min read
Business
2016 Royalties from Valeant Deal About Half the Amount of 2015, Says MEDA
November 16, 2015
 · 
1 min read
Load More